Cytosurge AG

Cytosurge AG Leverage Cytosurge’s proprietary FluidFM® technology for precise, gentle single-cell manipulation and CRISPR engineering.

Our vision is to turn genetic designs into cures, bridging design and manufacturing > https://linktr.ee/cytosurge Cytosurge develops innovative research solutions using its proprietary FluidFM® technology for precise single-cell manipulation thereby fostering advancements in understanding cellular processes such as the ones that drive cancer. With the FluidFM OMNIUM platform, single-cell extracts, or “biopsies” can be taken from living cells, enabling live-sequencing and temporal transcriptomics analysis. Additionally, the CellEDIT Service provides high-quality genetically engineered cell lines through intra-nuclear injections of CRISPR RNPs. Cytosurge's vision is to unlock novel cures by translating next-generation genetic designs into living cells, enabling longer and healthier lives through precision gene engineering. The Company aims to implement advanced genetically engineered cell lines that bring next-generation therapies to fruition, bridging the gap between genetic design tools and manufacturing, and empowering genetic engineers to realize their visionary concepts.

Grateful to GenomeWeb and Huanjia Zhang for the coverage and for speaking with our CPO, Dario Ossola. The interview foll...
14/11/2025

Grateful to GenomeWeb and Huanjia Zhang for the coverage and for speaking with our CPO, Dario Ossola. The interview follows our announcement that the Live‑seq workflow, built on FluidFM and developed with Lexogen, is ready for academic and industrial researchers worldwide. 🚀

Interested in hearing directly from the scientists behind it? Watch the recording of our recent webinar with Lexogen. 🎥🧬 LINK IN THE FIRST COMMENT 👇

What Live‑seq enables:
> Minimally invasive cytoplasmic sampling via FluidFM
> Point‑and‑click operation on the FluidFM OMNIUM platform
> Ultra‑low input library prep optimized with Lexogen’s LUTHOR HD
> Practical throughput: ~1 extraction every 6–10 minutes (≈20 biopsies per half day)
> Ideal for tracking drug response, cell fate, and disease progression over time

Read the article > Cytosurge Eyes Slice of Single‑Cell Market With Live‑seq Technology > https://bit.ly/4p5XLdp

From novel technologies to clinical applications: driving the next generation of multi-omics research. 🚀🧬Join Cytosurge ...
13/11/2025

From novel technologies to clinical applications: driving the next generation of multi-omics research. 🚀🧬

Join Cytosurge at NextGen Omics, Spatial & Data UK 13 - 14 Nov. | London
📌 BOOTH #47
🗣️ Featured Talk, TODAY, 4:10 PM, conference room 3
“Cellular Time Travel: Determine Today’s Transcriptome, Study Tomorrow’s Response” presented by Marlies Mürnseer, International Sales & BD Manager. On-site, also our CCO, Dr. Magid Haddouchi.

What you’ll learn in the talk:
> How to sequence RNA from living cells while keeping them alive
> Tracking the same cell’s molecular changes across time points
> Capturing causally linked transcriptomic and phenotypic data
> Understanding cellular responses and fate decisions in real time
> Bridging spatial and temporal omics for deeper biological insight

United in purpose: where omics meets data analysis. Together, we can accelerate life‑saving treatments with innovation, cross‑border collaboration, and precision technology.

12/11/2025

Margot Le Bot, PhD student in the Physics of Cells and Cancer Unit at Institut Curie (supervised by Benoît Sorre and Leïla Perié), shares how and technology are transforming her research on epithelial-to-mesenchymal transition (EMT) in triple-negative breast cancer.

Using FluidFM biopsies and full-life experiments, Margot:
• Tracks the same living cancer cell over time to understand heterogeneity
• Maps transcriptomic changes during this dynamic transition process
Studies how initial cell states influence metastatic outcomes
• Plans to expand to chemotherapy responses and transitions

This work is conducted at Institut Curie in collaboration with the Single Cell Initiative, under the management of Dr. Leanne de Koning.

Link to the recording & slides of our recent Live-seq in the first comment.

Dr. Tobias Beyer (CSO) will be at the CSHL Single Cell Analyses Meeting, Nov 12–15, 2025 (Cold Spring Harbor Laborator...
11/11/2025

Dr. Tobias Beyer (CSO) will be at the CSHL Single Cell Analyses Meeting, Nov 12–15, 2025 (Cold Spring Harbor Laboratory, NY), presenting a 2‑minute flash talk and a poster: “The FluidFM Technology for Temporally Resolved Single Cell Analysis, Genome Engineering and Beyond.”

Meet him there and don’t miss this opportunity to discover how FluidFM’s versatile platform is pushing the boundaries of what’s possible in single‑cell biology.

World Science Day for Peace and Development 🌍🔬 Celebrated every 10 November, today spotlights science’s role in society—...
10/11/2025

World Science Day for Peace and Development 🌍🔬 Celebrated every 10 November, today spotlights science’s role in society—building public trust, accelerating transformation, and shaping a better tomorrow. This year’s theme: Trust, Transformation, and Tomorrow — The Science We Need for 2050.

UNESCO is marking the day at the 43rd session of the UNESCO General Conference in Samarkand, Uzbekistan. Everyone can watch the live side event and join the conversation. Watch live: https://bit.ly/3JTl7nC

Celebrating Marie Curie’s birthday — November 7, 1867 ✨ Pioneer of radioactivity, first woman to win a Nobel Prize, firs...
07/11/2025

Celebrating Marie Curie’s birthday — November 7, 1867 ✨ Pioneer of radioactivity, first woman to win a Nobel Prize, first person (and only woman) to win two Nobels in two different sciences, and the first woman to lecture at the Sorbonne. Her legacy is a blueprint for inclusive science and bold innovation. “Nothing in life is to be feared, it is only to be understood.” — Marie Curie

Live seq : now on demand ▶️ Track the same living cell over time with non-destructive cytoplasmic biopsies 🧫⏱️.See the ...
05/11/2025

Live seq : now on demand ▶️ Track the same living cell over time with non-destructive cytoplasmic biopsies 🧫⏱️.
See the end-to-end workflow, instrumentation, and analysis, hosted by Dr. Ludovica Rizzo (Cytosurge) and Dr. Filippo Passardi (Lexogen). Watch and download the slides: https://bit.ly/3WDF4Sb

Did you know we have a blog? Get behind-the-scenes insights from customers who worked with us and read success stories f...
04/11/2025

Did you know we have a blog? Get behind-the-scenes insights from customers who worked with us and read success stories from projects: from tricky edits to clean outcomes with high viability. Explore the latest posts and subscribe to stay up to date on new releases, webinars, and tips.

• Read the blog: https://bit.ly/3QwTmRo
• Subscribe to our newsletter: https://bit.ly/4hoYinh

🧬 With CellEDIT, it’s a trick for the cells… 🔧 …but a treat for your research.Why gamble with transfection when you can ...
31/10/2025

🧬 With CellEDIT, it’s a trick for the cells… 🔧 …but a treat for your research.

Why gamble with transfection when you can go straight to the nucleus? 👻 No hocus-pocus. Just ultra-precise intra-nuclear gene editing with FluidFM.
🧟‍♀️ Leave the zombie cells to Halloween. We deliver engineered lines that are alive, targeted, and on point.
✨ Say goodbye to inefficiency and hello to customized cell lines that talk back.

Because in the world of gene editing, precision is the sweetest treat. 🍬

🎃

In single-cell research, it’s not the dead you should fear — it’s the silence.🧬 To truly understand cellular behavior or...
31/10/2025

In single-cell research, it’s not the dead you should fear — it’s the silence.
🧬 To truly understand cellular behavior or the impact of treatments…
💀 Don’t kill the conversation before it starts.

That’s why we use Live-seq powered by the FluidFM OMNIUM, to capture each cell’s voice, in its own time and state.

No tricks. Just precise, live-cell data. 🕸️🧫
Keep it alive. Keep it real. Keep it talking.

🎃

29/10/2025

TODAY! Time travel with Cytosurge and Lexogen. Discover what we have prepared for scientists interested in following a cell’s fate by RNA-seq!

🎤 Join Drs. Ludovica Rizzo and Filippo Passardi live at 3 PM CET / 10 AM EDT or access the recording afterward 👉 https://bit.ly/4qBzHAU

Adresse

Sägereistrasse 25
Glattbrugg
8152

Öffnungszeiten

Montag 09:00 - 18:00
Dienstag 09:00 - 18:00
Mittwoch 09:00 - 18:00
Donnerstag 09:00 - 18:00
Freitag 09:00 - 18:00

Telefon

+41445331450

Webseite

Benachrichtigungen

Lassen Sie sich von uns eine E-Mail senden und seien Sie der erste der Neuigkeiten und Aktionen von Cytosurge AG erfährt. Ihre E-Mail-Adresse wird nicht für andere Zwecke verwendet und Sie können sich jederzeit abmelden.

Verknüpfungen

Teilen

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Our Story

Founded in 2009, Cytosurge AG successfully develops, manufactures and distributes cutting-edge and unique high-precision nanotechnology instruments as well as robotic systems based on its patented FluidFM® technology.

Whether via the FluidFM ADD-ON, a powerful upgrade solution for your AFM, the FluidFM BOT, a fully integrated system for cell research, or via the award-winning FluidFM µ3Dprinter for 3D metal printing at the micrometre scale, Cytosurge provides leading-edge tools and processes to those who need or want to go beyond current technological boundaries.

FluidFM – GO BEYOND.